PRKG1 gene therapy

PRKG1 gene therapy has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 25, 2022: “Chronological attenuation of NPRA/PKG/AMPK signaling promotes vascular aging and elevates blood pressure”.